1.
Eur J Emerg Med
; 29(6): 461, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36300316
2.
Eur J Emerg Med
; 29(2): 140-141, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35210378
3.
Eur J Emerg Med
; 13(6): 358-60, 2006 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17091059
RESUMO
Increased risk of severe and resistant anaphylactic shock is a rare and not widely known adverse effect of beta-blocker treatment. It is illustrated in a case of refractory anaphylactic shock occurring in a 47-year-old woman who received beta-blockers. Actually, beta-blockers increase the release of anaphylactic mediators, decrease the cardiovascular compensatory changes to the anaphylactic shock and promote paradoxical reflex vagotonic effects when using epinephrine.